Autifony Therapeutics
London
About Autifony Therapeutics
Autifony Therapeutics Limited, a biotechnology company, develops medicines to treat hearing disorders such as hearing loss and tinnitus. The company was incorporated in 2011 and is based in London, United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $39.7M
- Last round: Series Unknown (Mar 2017)
- Website: autifony.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/autifony-therapeutics-19438 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.